{
    "nct_id": "NCT05952934",
    "official_title": "A Phase II Clinical Trial of Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence",
    "inclusion_criteria": "* Able to provide informed consent\n* Male or female 18 years of age or older\n* Squamous cell carcinoma of the head and neck who have completed curative therapy (surgery and/or radiation and/or chemotherapy) within the previous 120 days.\n* No Evidence of Disease (NED) based on clinical and/or radiographic evaluations\n* Willing and able to comply with the requirements of the protocol\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 100 Years",
    "exclusion_criteria": "* Positive urine pregnancy test for women of childbearing potential\n* Being pregnant or attempting to be pregnant with the period of study participation\n* Women who are breast feeding or plan to breast feed within the period of study participation\n* Patients who are allergic to CandinÂ®\n* If in the opinion of the PIs or other Investigators, it is not in the best interest of the patient to enter or continue in this study",
    "miscellaneous_criteria": ""
}